These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6828876)

  • 1. Radiation exposures in Utah from Nevada Nuclear Tests.
    Beck HL; Krey PW
    Science; 1983 Apr; 220(4592):18-24. PubMed ID: 6828876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individual external exposures from Nevada Test Site fallout for Utah leukemia cases and controls.
    Lloyd RD; Gren DC; Simon SL; Wrenn ME; Hawthorne HA; Lotz TM; Stevens W; Till JE
    Health Phys; 1990 Nov; 59(5):723-37. PubMed ID: 2211126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Historical estimates of external gamma exposure and collective external gamma exposure from testing at the Nevada Test Site. II. Test series after Hardtack II, 1958, and summary.
    Anspaugh LR; Ricker YE; Black SC; Grossman RF; Wheeler DL; Church BW; Quinn VE
    Health Phys; 1990 Nov; 59(5):525-32. PubMed ID: 2211112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Historical estimates of external gamma exposure and collective external gamma exposure from testing at the Nevada Test Site. I. Test series through HARDTACK II, 1958.
    Anspaugh LR; Church BW
    Health Phys; 1986 Jul; 51(1):35-51. PubMed ID: 3332000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of the National Cancer Institute's activities related to exposure of the public to fallout from the Nevada Test Site.
    Wachholz BW
    Health Phys; 1990 Nov; 59(5):511-4. PubMed ID: 2211110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Utah Thyroid Cohort Study: analysis of the dosimetry results.
    Till JE; Simon SL; Kerber R; Lloyd RD; Stevens W; Thomas DC; Lyon JL; Preston-Martin S
    Health Phys; 1995 Apr; 68(4):472-83. PubMed ID: 7883559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimates of exposure rates and fallout arrival times near the Nevada Test Site.
    Thompson CB
    Health Phys; 1990 Nov; 59(5):555-63. PubMed ID: 2211115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioactive fallout reconstruction from contemporary measurements of reservoir sediments.
    Krey PW; Heit M; Miller KM
    Health Phys; 1990 Nov; 59(5):541-54. PubMed ID: 2211114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Childhood leukemia and fallout from the Nevada nuclear tests.
    Land CE; McKay FW; Machado SG
    Science; 1984 Jan; 223(4632):139-44. PubMed ID: 6691139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cohort study of thyroid disease in relation to fallout from nuclear weapons testing.
    Kerber RA; Till JE; Simon SL; Lyon JL; Thomas DC; Preston-Martin S; Rallison ML; Lloyd RD; Stevens W
    JAMA; 1993 Nov; 270(17):2076-82. PubMed ID: 8411574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermoluminescence measurements of gamma-ray doses attributable to fallout from the Nevada test site using building bricks as natural dosimeters.
    Haskell EH; Bailiff IK; Kenner GH; Kaipa PL; Wrenn ME
    Health Phys; 1994 Apr; 66(4):380-91. PubMed ID: 8138403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Utah Leukemia Case-Control Study: dosimetry methodology and results.
    Simon SL; Till JE; Lloyd RD; Kerber RL; Thomas DC; Preston-Martin S; Lyon JL; Stevens W
    Health Phys; 1995 Apr; 68(4):460-71. PubMed ID: 7883558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid disease associated with exposure to the Nevada nuclear weapons test site radiation: a reevaluation based on corrected dosimetry and examination data.
    Lyon JL; Alder SC; Stone MB; Scholl A; Reading JC; Holubkov R; Sheng X; White GL; Hegmann KT; Anspaugh L; Hoffman FO; Simon SL; Thomas B; Carroll R; Meikle AW
    Epidemiology; 2006 Nov; 17(6):604-14. PubMed ID: 17028502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The assessment of radiation exposures in Native American communities from nuclear weapons testing in Nevada.
    Frohmberg E; Goble R; Sanchez V; Quigley D
    Risk Anal; 2000 Feb; 20(1):101-11. PubMed ID: 10795343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External exposure estimates for individuals near the Nevada Test Site.
    Henderson RW; Smale RF
    Health Phys; 1990 Nov; 59(5):715-21. PubMed ID: 2211125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer incidence in an area of radioactive fallout downwind from the Nevada Test Site.
    Johnson CJ
    JAMA; 1984 Jan; 251(2):230-6. PubMed ID: 6690781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cohort study of thyroid disease near the Nevada Test Site: a preliminary report.
    Rallison ML; Lotz TM; Bishop M; Divine W; Haywood K; Lyon JL; Stevens W
    Health Phys; 1990 Nov; 59(5):739-46. PubMed ID: 2211127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukemia in Utah and radioactive fallout from the Nevada test site. A case-control study.
    Stevens W; Thomas DC; Lyon JL; Till JE; Kerber RA; Simon SL; Lloyd RD; Elghany NA; Preston-Martin S
    JAMA; 1990 Aug; 264(5):585-91. PubMed ID: 2366297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meteorological modeling of arrival and deposition of fallout at intermediate distances downwind of the Nevada Test Site.
    Cederwall RT; Peterson KR
    Health Phys; 1990 Nov; 59(5):593-601. PubMed ID: 2211118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External radiation exposure to the offsite population from nuclear tests at the Nevada Test Site between 1951 and 1970.
    Shleien B
    Health Phys; 1981 Aug; 41(2):243-54. PubMed ID: 7275609
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.